2-(3-ôÈ»ù-1-±ûõ£°±»ù)-2-ÍÑÑõ-D-ÆÏÌÑÌÇ,2-(3-carboxy-1-oxopropyl)amino-2-deoxy-D-GlucoseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²Ï¶¹¸ù¼â΢ºË¼¼Êõ,VAMCNÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θʳ¹ÜÎǺÏÊõ,GastroesophagectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂÌŧ¸Ë¾úÖÆ¼Á,PA-MSHAÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºÚÉ«ËØÁö/Íâ¿ÆÑ§,melanoma/SUÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²¡ËÀ,fatalityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°¬Á¦,CPT-¢òÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±íÃæÔöÇ¿¼¤¹â½âÎüµçÀë-·ÉÐÐʱ¼äÖÊÆ×,SELDI-TOF-MSÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÁÀûÌæ¿µ,IrinotecanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁܰÍÁö/²¢·¢Ö¢,Lymphoma/COÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
5-LOX,5-lipoxygeaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×Áö·¢Éú·¢Õ¹,tamorigenesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼×»ùÁò´úÏÙÜÕ,methylthioadenosineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
RKOϸ°û,RKOÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ËÀÍöÊÜÌå4,DcR1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×Áö½µÆÚ,Down-stagingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
mp53,VEGFÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÇѪÐÔ,Non-bloodyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÆÕ³µ°°×»ùÒò,E-cadherinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Áò»ù×ªÒÆÃ¸Àà,SulfurtransferasesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Àû¿¨Í¡,LicartinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÁÁ¢Ì濵(CPT-11),Irinotecan(CPT-11)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·úÄòà×à¤/ÑÇÒ¶Ëá¸Æ,fluorouracilÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½á³¦ÇгýÊõ/·½·¨,Colectomy/methodsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ½¬TÁܰÍϸ°ûAgNORs,Tc-AgÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ñ»µ¨×ÓÈé¼Á,YaDanZiRuJiÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¥²ãÎǺÏÊõ,AnastomosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÅÉäѧ/½éÈëÐÔ,Radiology/InterventionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
P16/ÃâÒßѧ,P16/immunologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
herg1»ùÒò,herg1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ¹Ü¼¡Ö¬Áö/²¡Àíѧ,angionyolipoma/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
I-¦ÊB¦Á,¢ñ-¦ÊB¦ÁÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÉÃ×ÄÒÅÝ,niosomesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
PD 98059,PD98059Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½á¹¹Ö¬·¾Èé¼Á,StructolipidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿¹ÔCD117,CD117Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ѪÇåÉúÀíѧ,serophysiologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄÚÀ¨Ô¼¼¡ÇгýÊõ,BiofeedbackÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Á×Ö¬õ£ÒÒ´¼°·-N-¼×»ù×ªÒÆÃ¸2,Phosphatidylethanolamine-N-methyltransferase-2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈËÊÈËáÐÔϸ°ûÉñ¾¶¾ËØ,hEDNÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºÉ°üǯ,SSTÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢´´Ê³¹ÜÇгýÊõ,esophagectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍØÆËÒ칹ø-1,Topoisomerase-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Î¶¯ÂöÔìÓ°CT,SD-CTHAÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°û½ÇÖʵ°°×19Ƭ¶Î,CYFRA211Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʳ¹ÜθÎǺϿÚÏÁÕ,dilatationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔÙÊÖÊõÇгý,re-resectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ephrin B2,ephrinB2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁܰÍÁö/Íâ¿ÆÑ§,lymphoma/SUÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¨µÀ°©Ë¨,TTBDÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ÔÉíÃâÒß¿¹Ìå,self-antibodyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÈÐÝ¿Ëת¼Òò×Ó1,hHSF1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Òº»ù±¡Æ¬,ThinprepÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Õ³Òº/Õï¶Ï,mucinous/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ¨¹Ì´¼/²¡Òòѧ,cholesterol/etiolÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Î¶¯Âöµ¼¹Ü»¯ÁÆË¨Èû,HAEÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
DCC»ùÒò,DCCÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θ¹¦ÄÜÐÔÅÅ¿ÕÕϰ,GastroplegiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÈ»¯ÁÆË¨Èû,ThermochemoembolotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
˨Èû/ÖÎÁÆÐÔ,Embolization/therapeuticÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÒ×´½á³¦¾µ,SigmoidoscopeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊõºóÉú´æ,prognosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³É½ºÖÊϸ°ûÁö,GlioblastomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
HNF6,HNF?6Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·´Òå¹ÑºËÜÕËá¼¼Êõ,As-ODNÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
p21WAF,p21~(WAF)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°ûÍâÐźŵ÷½Ú¼¤Ã¸5,ERK5Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Õï¶ÏÔ¤²â,judgement-predictionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
GLQIÖ¸Êý,GLQIÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´¨±±µØÇø,North-SichuanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ƽ»¬¼¡ÈâÁö/Õï¶Ï,leiomyosarcoma/diagonosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
È˽᳦°©Ï¸°ûCaco-2,Caco-2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍÃÁÛ°©Ï¸°ûÖê,VX2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈËθ°©SGC-7901ϸ°û,SGC-7901Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°©Åß¿¹Ôµ°°×,CEApÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÀÒË¿çÓëÄ(YSV),YSVÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²Ð°©,MetastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½µÆÚ,downstageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ôª±¦·ã»ÆÍª,FlavoneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÈÏÙµ¼¹ÜÄÚÈéÍ·×´Õ³ÒºÐÔÖ×Áö,IPMNÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Rho/ROCK,HBMECÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×éµ°°×ÍÑÒÒõ£»¯Ã¸ÒÖÖÆ¼Á,5-aza-cytidineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊõÖл¯ÁÆ,chemotheraÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
HtrA2/Omi,ParkinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢СRNA-122,miR-122Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½á³¦ÏµÄ¤,mesocolonÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½áµÞ×éÖ¯Áö,mesocytomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔöÖ³/µòÍö,proliferation/apoptosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µØÓòÏà¹ØÐÔ,region-restrictedÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éñ¾ºËµ°°×¦Ã,¦Ã-synÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
N-¾ÛÌÇ,N-glycanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑǸζÎ,SubsegmentalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
S-1,5-·úÄòà×à¤,s-1,5-FuÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
p16,5-µªÔÓ-2'-ÍÑÑõ°ûÜÕ(5-Aza-CdR),p16,5-aza-2'-deoxycytidineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
°ÂɳÀû²¬/»¯ÁÆ,oxaliplatin/chemotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
CDK2µ°°×,CDK2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
BRAFµ°°×,BRAFÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ËÁ£Ã¸Äæ×ªÂÌøÆô¶¯×Ó,mTERT-promoterÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¢ñÐÍPI3K,Class¢ñPI3KÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¢óÐÍPI3K,Class¢óPI3KÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|